CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 11, Pages 1803
Publisher
MDPI AG
Online
2019-11-18
DOI
10.3390/cancers11111803
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of ADAM12 as a Novel Basigin Sheddase
- (2019) Reidar Albrechtsen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chemoresistance in mesenchymal lung cancer cells is correlated to high regulatory T cell presence in the tumor microenvironment
- (2019) Li‐Na Zhang et al. IUBMB LIFE
- A novel antibody-drug conjugate, HcHAb18-DM1, has potent anti-tumor activity against human non-small cell lung cancer
- (2019) Muren Huhe et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CD73 complexes with emmprin to regulate MMP-2 production from co-cultured sarcoma cells and fibroblasts
- (2019) M. Aoki et al. BMC CANCER
- Integrin β1 regulates the invasion and radioresistance of laryngeal cancer cells by targeting CD147
- (2018) Li Li et al. Cancer Cell International
- Plasma soluble cluster of differentiation 147 levels are increased in breast cancer patients and associated with lymph node metastasis and chemoresistance
- (2018) YH Kuang et al. HONG KONG MEDICAL JOURNAL
- CD147 expression is associated with poor overall survival in chemotherapy treated triple-negative breast cancer
- (2018) Ming Liu et al. JOURNAL OF CLINICAL PATHOLOGY
- The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells
- (2018) Isabella Spinello et al. HAEMATOLOGICA
- CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling
- (2018) Binbin Yu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: A meta-analysis
- (2017) Hui Li et al. PLoS One
- Intratumor and Intertumor Heterogeneity in Melanoma
- (2017) Tomasz M. Grzywa et al. Translational Oncology
- The clinicopathological significance and prognostic value of EMMPRIN overexpression in cancers: evidence from 39 cohort studies
- (2017) Hengwei Fan et al. Oncotarget
- Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study
- (2017) Bing Liu et al. BMC Pulmonary Medicine
- Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression
- (2017) Dillon M. Voss et al. Scientific Reports
- EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma
- (2016) Anne Caudron et al. EXPERIMENTAL DERMATOLOGY
- Circulating CD147 predicts mortality in advanced hepatocellular carcinoma
- (2016) Aimei Lee et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The tumor microenvironment promotes cancer progression and cell migration
- (2016) Viviana Salvatore et al. Oncotarget
- A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells
- (2016) Zhi-guang Fu et al. Oncotarget
- How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity
- (2015) G. D. Grass et al. BIOSCIENCE REPORTS
- EMMPRIN regulatesβ1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells
- (2015) Julie Delyon et al. EXPERIMENTAL DERMATOLOGY
- Soluble extracellular matrix metalloproteinase inducer (EMMPRIN, EMN) regulates cancer-related cellular functions by homotypic interactions with surface CD147
- (2015) Nadine Knutti et al. FEBS Journal
- Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners
- (2015) Takashi Muramatsu JOURNAL OF BIOCHEMISTRY
- Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features
- (2015) Xiuyun Tian et al. Journal of Translational Medicine
- Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study
- (2015) Tammer Hemdan et al. JOURNAL OF UROLOGY
- EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF
- (2015) Farah Khayati et al. Oncotarget
- Knock out of the BASIGIN/CD147 chaperone of lactate/H+ symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction
- (2015) Ibtissam Marchiq et al. Oncotarget
- An epitope-specific novel anti-EMMPRIN polyclonal antibody inhibits tumor progression
- (2015) Miriam Walter et al. OncoImmunology
- CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells
- (2015) Shi-Jie Wang et al. Oncotarget
- Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status
- (2015) Sara Granja et al. Oncotarget
- A novel tumor suppressor function of Kindlin-3 in solid cancer
- (2015) Ibtissem Djaafri et al. Oncotarget
- A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway
- (2014) Yuan Wang et al. CLINICAL & EXPERIMENTAL METASTASIS
- Anoikis molecular pathways and its role in cancer progression
- (2013) Paolo Paoli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- CD147 mediates chemoresistance in breast cancer via ABCG2 by affecting its cellular localization and dimerization
- (2013) Shuangyuan Zhou et al. CANCER LETTERS
- A novel role of EMMPRIN/CD147 in transformation of quiescent fibroblasts to cancer-associated fibroblasts by breast cancer cells
- (2013) Jing Xu et al. CANCER LETTERS
- CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells
- (2013) Denise K Walters et al. CELL CYCLE
- Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells
- (2013) SHINSUKE SUZUKI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- CD147 promotes MTX resistance by immune cells through up-regulating ABCG2 expression and function
- (2013) Shuang Zhao et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Prognostic significance of CD147 in patients with glioblastoma
- (2013) Min Yang et al. JOURNAL OF NEURO-ONCOLOGY
- Renal cell neoplasias: reversion-inducing cysteine-rich protein with Kazal motifs discriminates tumor subtypes, while extracellular matrix metalloproteinase inducer indicates prognosis
- (2013) Anja Rabien et al. Journal of Translational Medicine
- CD147, MMP9 expression and clinical significance of basal-like breast cancer
- (2013) Ying Liu et al. MEDICAL ONCOLOGY
- EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome
- (2013) Mototaka Sato et al. PLoS One
- Dimerization is essential for HAb18G/CD147 promoting tumor invasion via MAPK pathway
- (2012) Hong-Yong Cui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression
- (2012) Géraldine Lescaille et al. BMC CANCER
- Association of increased ligand cyclophilin A and receptor CD147 with hypoxia, angiogenesis, metastasis and prognosis of tongue squamous cell carcinoma
- (2012) Congfa Huang et al. HISTOPATHOLOGY
- High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer
- (2012) Albrecht Stenzinger et al. HUMAN PATHOLOGY
- Regulation of invadopodia formation and activity by CD147
- (2012) G. D. Grass et al. JOURNAL OF CELL SCIENCE
- Acquisition of anoikis resistance through CD147 upregulation: A new mechanism underlying metastasis of hepatocellular carcinoma cells
- (2012) XIA KE et al. Oncology Letters
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Expression of CD147 is associated with prostate cancer progression
- (2011) Wei-de Zhong et al. INTERNATIONAL JOURNAL OF CANCER
- Extracellular Membrane-proximal Domain of HAb18G/CD147 Binds to Metal Ion-dependent Adhesion Site (MIDAS) Motif of Integrin β1 to Modulate Malignant Properties of Hepatoma Cells
- (2011) Yong Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma
- (2011) Z Qin et al. LEUKEMIA
- Characterization of Basigin Isoforms and the Inhibitory Function of Basigin-3 in Human Hepatocellular Carcinoma Proliferation and Invasion
- (2011) C.-G. Liao et al. MOLECULAR AND CELLULAR BIOLOGY
- CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors
- (2011) R. Le Floch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancer
- (2011) Haining Zhu et al. PROSTATE
- Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model
- (2010) Nichole Renae Dean et al. ANTI-CANCER DRUGS
- Receptor Activator of NF- B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147
- (2010) N. Rucci et al. CANCER RESEARCH
- CD147 and VEGF Co-expression Predicts Prognosis in Patients with Acute Myeloid Leukemia
- (2010) Jufang Fu et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2
- (2010) Faten Bougatef et al. PLoS One
- EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2 -mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2
- (2009) F. Bougatef et al. BLOOD
- The interaction of HAb18G/CD147 with integrin α6β1 and its implications for the invasion potential of human hepatoma cells
- (2009) Jing-yao Dai et al. BMC CANCER
- CD147 and VEGF Expression in Advanced Renal Cell Carcinoma and Their Prognostic Value
- (2009) Yu-Xiang Liang et al. CANCER INVESTIGATION
- HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection
- (2009) Yu Li et al. HISTOPATHOLOGY
- Kindlin-3 is required for β2 integrin–mediated leukocyte adhesion to endothelial cells
- (2009) Markus Moser et al. NATURE MEDICINE
- Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
- (2009) O. M. Woodward et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Tail of Integrins, Talin, and Kindlins
- (2009) M. Moser et al. SCIENCE
- Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism
- (2008) Miyako Baba et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression
- (2008) Michele C. Madigan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Overexpression of HAb18G/CD147 promotes invasion and metastasis via α3β1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways
- (2008) J. Tang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Basigin-2 Is a Cell Surface Receptor for Soluble Basigin Ligand
- (2008) Robert J. Belton et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Crystal Structure of HAb18G/CD147
- (2008) Xiao-Ling Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9
- (2008) Wulf Sienel et al. MODERN PATHOLOGY
- Direct epithelial–stromal interaction in corneal wound healing: Role of EMMPRIN/CD147 in MMPs induction and beyond
- (2008) Eric E. Gabison et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Extracellular Matrix Metalloproteinase Inducer (CD147) Is a Novel Receptor on Platelets, Activates Platelets, and Augments Nuclear Factor κB–Dependent Inflammation in Monocytes
- (2007) Roland Schmidt et al. CIRCULATION RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now